GW Pharma to launch first CBD-based epilepsy drug in Europe 'over the next year or two,' CEO says
GW Pharma has been cleared to market the first plant-derived cannabis-based medicine in Europe to treat epilepsy conditions, CEO Justin Gover told …
GW Pharma has been cleared to market the first plant-derived cannabis-based medicine in Europe to treat epilepsy conditions, CEO Justin Gover told …